Proteon Therapeutics and Lonza Extend Manufacturing Agreement for Commercial Supply
May 08, 2018 07:00 ET
|
Proteon Therapeutics, Inc.
Partners extend existing contract for manufacture of vonapanitase to 2029 as ongoing Phase 3 trial nears completionLonza Pharma & Biotech successfully scaled up a lab process at their Microbial...
Who’s your hero? Nominations open for American Kidney Fund 2018 Hero of Hope
April 25, 2018 15:46 ET
|
American Kidney Fund
ROCKVILLE, Maryland, April 25, 2018 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced it is accepting nominations in its 8th annual nationwide search for a Hero of Hope—an...
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2017 Financial Results
March 14, 2018 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics to Present at Two Upcoming Investor Conferences
March 06, 2018 16:45 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Completes Enrollment in PATENCY-2, Phase 3 Clinical Trial of Investigational Vonapanitase
March 05, 2018 17:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics to Present at the Stifel 2017 Healthcare Conference November 15th
November 08, 2017 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Announces Third Quarter 2017 Financial Results
November 07, 2017 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Satellite Healthcare to Present at American Society of Nephrology Annual Kidney Week Conference
October 31, 2017 09:03 ET
|
Satellite Healthcare
SAN JOSE, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis provider, today announced it will present three posters and host a NephTalk lounge for...
Proteon Therapeutics to Present at the Baird 2017 Global Healthcare Conference September 7, 2017
September 05, 2017 07:45 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Announces Second Quarter 2017 Financial Results
August 07, 2017 17:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...